Evipa SRL
Evipa reported total assets of €1.96m at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jun 2026).
The score of Evipa shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +34 % Total assets +31 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Evipa's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jun 2026
- Year ended 31 Dec 2024filed on 13 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jun 2024
- Year ended 31 Dec 2022filed on 02 Jul 2023
- Year ended 31 Dec 2021filed on 14 Jun 2022
Evipa's financial analysis
- Solvency89.6%sector median: 75.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Evipa
Evipa's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0546.730.996
- VAT number
- BE0546730996
- Peppol
- Registered · 0208:0546730996 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Feb 2014
- Registered office
- 9150 Beveren-Kruibeke-Zwijndrecht
- Latest accounts
- 2025 · filed on 28 Jun 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Evipa (SRL) has been based in Beveren-Kruibeke-Zwijndrecht since 2014, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 326,352 € and equity of €1.76m; its revenue is not published. Its solvency stands at 89.6%, above the median of its sector (75.0%).
Companies similar to Evipa
Companies in the same business, of comparable size and area, outside its group.
- Sicher Research and experimental development on natural sciences and engineering Balen · balance sheet 246,186 €
- Koios Care Research and experimental development on natural sciences and engineering Antwerp · balance sheet €1.01m
- Biomedical Application OF Research IN Infectious Diseases Control Research and experimental development on natural sciences and engineering Ghent · balance sheet €3.69m
- Epsilon-Biotech Research and experimental development on natural sciences and engineering Zonhoven · balance sheet 244,785 €
- GC Laboratory Europe Technical testing and analysis Leuven · balance sheet 406,216 €
- Biocli Consult Research and experimental development on natural sciences and engineering Jurbise · balance sheet 302,775 €
- Taag Europe All other professional, scientific and technical activities n.e.c. Antwerp · balance sheet 729,485 €
- Malajo Medical General medical practice activities Genappe · balance sheet 763,973 €
Frequently asked questions about Evipa
What is the revenue of Evipa?
Evipa files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Evipa?
In Belgium, the VAT number is the company number prefixed with BE: BE0546730996 for Evipa, if the company is VAT-registered. Its company number (CBE) is 0546.730.996.
Where is the registered office of Evipa?
According to the CBE register, the registered office of Evipa is in 9150 Beveren-Kruibeke-Zwijndrecht.
What is the equity of Evipa?
At the close of the 2025 financial year, the equity of Evipa amounts to 1,759,404 €, a solvency of 89.6% of total assets.
Who manages Evipa?
The register lists 1 active mandates at Evipa. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Evipa
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →